![Niklas Axelsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Niklas Axelsson
Director of Finance/CFO at
DIAMYD MEDICAL AB
Net worth: 605 $ as of 2026-05-30
Profile
Niklas Axelsson is currently Chief Financial Officer at Diamyd Medical AB since 2025.
Formerly, Mr. Axelsson was Chief Financial Officer at Sprint Bioscience AB. Education includes an undergraduate degree from Stockholm School of Economics.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-08-30 | 5,000 ( 0% ) | 605 $ | 2026-05-30 |
Niklas Axelsson active positions
| Companies | Position | Start |
|---|---|---|
| DIAMYD MEDICAL AB | Director of Finance/CFO | 2024-12-31 |
Former positions of Niklas Axelsson
| Companies | Position | End |
|---|---|---|
| SPRINT BIOSCIENCE AB | Director of Finance/CFO | - |
Training of Niklas Axelsson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Stockholm School of Economics
 Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sprint Bioscience AB
 Sprint Bioscience AB Pharmaceuticals: MajorHealth Technology Develops medicines in the field of cancer and metabolism | Health Technology |
Diamyd Medical AB
 Diamyd Medical AB Pharmaceuticals: MajorHealth Technology Develops precision medicine drugs for type 1 diabetes and other forms of autoimmune diabetes | Health Technology |
- Stock Market
- Insiders
- Niklas Axelsson
